Study to Investigate the Pharmacokinetics and Safety of Cadazolid in Patients With Clostridium Difficile Infection
Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The study investigated the pharmacokinetics, safety, and tolerability of cadazolid in
subjects with severe Clostridium difficile diarrhea (CDAD) and whether this influenced the
quantity of cadazolid absorbed into the systemic circulation.